For pharmaceutical manufacturers, the quality of raw materials directly influences the efficacy and safety of the final drug product. When incorporating specialized compounds like BENZENEACETIC ACID, 4-(2-(4-(1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOL-2-YL)-1-PIPERIDINYL)ETHYL-ALPHA, ALPHA-DIMETHYL- (CAS 202189-78-4) into Active Pharmaceutical Ingredient (API) synthesis, understanding key specifications is non-negotiable. As a leading pharmaceutical intermediate manufacturer, we prioritize clarity and precision in our product data.

The most critical specification for any pharmaceutical intermediate is its purity. Our BENZENEACETIC ACID, 4-(2-(4-(1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOL-2-YL)-1-PIPERIDINYL)ETHYL-ALPHA, ALPHA-DIMETHYL- is consistently supplied with a minimum purity of 99%. This high level of purity is essential for preventing side reactions and ensuring the desired therapeutic outcome in the final API. Another important characteristic is the physical form; this intermediate is supplied as a white powder, making it easy to handle and integrate into various chemical processes. Buyers looking to buy pharmaceutical intermediates should always verify these details.

The primary application of BENZENEACETIC ACID, 4-(2-(4-(1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOL-2-YL)-1-PIPERIDINYL)ETHYL-ALPHA, ALPHA-DIMETHYL- is in the synthesis of antihistamines. This specific use case dictates a need for high reliability and traceability from the chemical supplier in China. When you purchase CAS 202189-78-4, you are investing in a crucial component for potentially life-saving medications. Therefore, verifying the supplier's compliance certifications, such as ISO, is also a critical step in the procurement process.

For companies requiring this intermediate, obtaining a detailed datasheet and a competitive price quote is the next step. As a prominent supplier of fine chemicals, we are committed to providing comprehensive information and responsive service to meet the rigorous demands of API manufacturing. Partner with us to ensure the quality and consistency of your pharmaceutical supply chain.